Lilly Acquires Phase III Intranasal Glucagon from Locemia Solutions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. USO
5. AMC
6. MSFT
7. AMZN
8. ACN
9. FFAI
10. PAA

Go back to Lilly Acquires Phase III Intranasal Glucagon from Locemia Solutions
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1165.88 +12.95 (1.12%)
Previous Close $1152.93    52 Week High $88.16 
Open $1144.50    52 Week Low $67.88 
Day High $1168.44    P/E 269.88 
Day Low $1134.41    EPS $4.32 
Volume 572,097